Bellevue Life Sciences Acquisition Corp.
BLAC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $66 | $15 | $125 | $5 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $389 | $7 | $0 | $0 |
| Total Curr. Assets | $455 | $23 | $125 | $5 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $1,848 | $36,605 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $1,101 | $700 |
| Total NC Assets | $1,848 | $36,605 | $1,101 | $700 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $2,303 | $36,628 | $1,226 | $705 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $34 | $3 |
| Short-Term Debt | $1,763 | $0 | $1,200 | $400 |
| Tax Payable | $358 | $525 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $4,597 | $1,514 | $29 | $304 |
| Total Curr. Liab. | $6,719 | $2,038 | $1,263 | $707 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $2,070 | $2,070 | $0 | $0 |
| Total NC Liab. | $2,070 | $2,070 | $1,234 | $0 |
| Other Liabilities | $0 | $0 | -$1,234 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $8,789 | $4,108 | $1,263 | $707 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1,848 | $36,426 | $0 | $0 |
| Retained Earnings | -$8,334 | -$3,907 | -$63 | -$27 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $0 | $0 | $25 | $25 |
| Total Equity | -$6,486 | $32,519 | -$38 | -$2 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $2,303 | $36,628 | $1,226 | $705 |
| Net Debt | $1,697 | -$15 | $1,075 | $395 |